Get the Stockscreener App
1.74
0.00%
0.00
After Hours:
1.74
Pulmonx Corp stock is traded at $1.74, with a volume of 304.19K.
It is up +0.00% in the last 24 hours and up +6.10% over the past month.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
See More
Previous Close:
$1.74
Open:
$1.74
24h Volume:
304.19K
Relative Volume:
0.50
Market Cap:
$70.90M
Revenue:
$68.68M
Net Income/Loss:
$-60.84M
P/E Ratio:
-1.0875
EPS:
-1.6
Net Cash Flow:
$-38.42M
1W Performance:
+1.75%
1M Performance:
+6.10%
6M Performance:
-78.75%
1Y Performance:
-74.93%
1-Day Range:
$1.675
$1.795
1-Week Range:
$1.5901
$1.85
52-Week Range:
$1.47
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Name
Pulmonx Corp
Sector
Industry
Phone
650-364-0400
Address
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.74 | 70.90M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-10-25 | Initiated | D. Boral Capital | Buy |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-04-24 | Initiated | Lake Street | Buy |
| Feb-23-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-05-23 | Initiated | Craig Hallum | Buy |
| Feb-27-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Mar-25-21 | Initiated | Piper Sandler | Neutral |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-20 | Initiated | BofA Securities | Buy |
| Oct-26-20 | Initiated | Canaccord Genuity | Buy |
| Oct-26-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-26-20 | Initiated | Stifel | Buy |
| Oct-26-20 | Initiated | Wells Fargo | Equal Weight |
View All
Pulmonx Corp Stock (LUNG) Latest News
What Fibonacci levels say about Pulmonx Corporation reboundGap Up & Free Fast Entry Momentum Trade Alerts - Newser
How to track smart money flows in Pulmonx Corporation2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - Newser
Using R and stats models for Pulmonx Corporation forecasting2025 Market Outlook & Smart Swing Trading Alerts - Newser
Using economic indicators to assess Pulmonx Corporation potentialFed Meeting & Proven Capital Preservation Methods - Newser
Is Pulmonx Corporation stock poised for growthJuly 2025 Recap & Reliable Entry Point Trade Alerts - Newser
Backtesting results for Pulmonx Corporation trading strategiesTreasury Yields & AI Forecasted Stock Moves - Newser
Can trapped investors hope for a rebound in Pulmonx CorporationMarket Trend Report & Weekly Top Gainers Trade List - Newser
Real time pattern detection on Pulmonx Corporation stock2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Chart based analysis of Pulmonx Corporation trends2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Pulmonx at Wells Fargo Conference: Strategic Growth and Challenges By Investing.com - Investing.com South Africa
Pulmonx Corporation Reaches Critical Trendline SupportWeekly Risk Summary & Safe Swing Trade Setup Alerts - beatles.ru
Pulmonx at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com
Will Pulmonx Corporation stock recover after recent dropJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Pattern recognition hints at Pulmonx Corporation upsideSell Signal & High Return Stock Watch Alerts - Newser
Will Pulmonx Corporation bounce back from current supportJuly 2025 Rallies & Daily Chart Pattern Signals - Newser
Pulmonx Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Will breakout in Pulmonx Corporation lead to full recoveryJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
How to build a custom watchlist for Pulmonx CorporationWeekly Profit Summary & Weekly High Potential Stock Alerts - Newser
Using data tools to time your Pulmonx Corporation exitJuly 2025 Institutional & Verified Short-Term Plans - Newser
What data driven models say about Pulmonx Corporation’s future2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
What are the future prospects of Pulmonx CorporationMarket Volume Report & Long-Term Safe Investment Plans - khodrobank.com
Does Pulmonx Corporation fit your quant trading model2025 Performance Recap & AI Powered Buy/Sell Recommendations - Newser
How sentiment analysis helps forecast Pulmonx CorporationCPI Data & Weekly Return Optimization Plans - Newser
Is Pulmonx Corporation meeting your algorithmic filter criteriaTrade Performance Summary & AI Optimized Trade Strategies - Newser
Trend analysis for Pulmonx Corporation this weekQuarterly Trade Review & Technical Pattern Based Buy Signals - Newser
Is it time to cut losses on Pulmonx CorporationVolume Spike & Daily Volume Surge Signals - Newser
How to escape a deep drawdown in Pulmonx Corporation2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Real time alert setup for Pulmonx Corporation performanceTrade Ideas & Stepwise Trade Signal Implementation - Newser
Pulmonx (NASDAQ:LUNG) Upgraded by Wall Street Zen to Hold Rating - Defense World
Pulmonx Corp Stock (LUNG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):